UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Rede Wealth LLC

Rede Wealth LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,366 shares of the healthcare conglomerate’s stock after selling 253 shares during the quarter. UnitedHealth Group accounts for about 0.7% of Rede Wealth LLC’s portfolio, making the stock its 17th biggest holding. Rede Wealth LLC’s holdings in UnitedHealth Group were worth $1,703,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Howland Capital Management LLC increased its position in shares of UnitedHealth Group by 12.0% during the 4th quarter. Howland Capital Management LLC now owns 1,144 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 123 shares during the last quarter. Birch Hill Investment Advisors LLC grew its position in shares of UnitedHealth Group by 33.6% during the fourth quarter. Birch Hill Investment Advisors LLC now owns 1,161 shares of the healthcare conglomerate’s stock worth $587,000 after buying an additional 292 shares in the last quarter. AlphaStar Capital Management LLC lifted its stake in UnitedHealth Group by 24.6% during the fourth quarter. AlphaStar Capital Management LLC now owns 870 shares of the healthcare conglomerate’s stock worth $440,000 after purchasing an additional 172 shares during the last quarter. WCM Investment Management LLC lifted its stake in UnitedHealth Group by 0.6% during the fourth quarter. WCM Investment Management LLC now owns 1,211,222 shares of the healthcare conglomerate’s stock worth $615,058,000 after purchasing an additional 6,637 shares during the last quarter. Finally, Empowered Funds LLC lifted its stake in UnitedHealth Group by 25.9% in the fourth quarter. Empowered Funds LLC now owns 40,399 shares of the healthcare conglomerate’s stock valued at $20,436,000 after buying an additional 8,302 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $526.68 on Friday. The business’s 50-day moving average price is $529.18 and its 200 day moving average price is $564.30. The company has a market capitalization of $484.69 billion, a PE ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.